Calibre Scientific is pleased to announce that it has completed the acquisition of Kalon Biological Limited and Clin-Tech Limited (together “KalonBio“ or the “Company”). The Company specializes in the development and manufacture of a range of medical diagnostic kits, commercial ELISA (enzyme immunoassays [EIA]) kits and reagents for the healthcare and life sciences industry.
Read MoreStoneCalibre is pleased to announce that as of September 14, 2018, it has completed the divestiture of the handheld network test (HNT) tools business from NETSCOUT SYSTEMS, INC. (NASDAQ: NTCT). StoneCalibre has acquired this pioneering portfolio of HNT solutions along with a global team of experienced executives, product engineers, sales, marketing and operations professionals. Terms of the transaction were not disclosed.
Read MoreCalibre Scientific is pleased to announce that it has completed the acquisition of PhytoTechnology Laboratories, LLC (“PhytoTech Labs“ or the “Company”), a provider of products for plant molecular biology and plant tissue culture research sold throughout the world.
Read MoreCalibre Scientific is pleased to announce that it has completed the acquisition of BIOZOL Diagnostica Vertrieb GmbH (“BIOZOL“ or the “Company”), an independent distributor of life science products across Germany.
Read MoreCalibre Scientific is pleased to announce that it has completed the acquisitions of Protein Ark and BioServUK (together the “Companies“), providers of custom and off-the-shelf proteins, antibodies and other products utilized by the academic life science research and diagnostics communities. The inclusion of BioServUK and Protein Ark allows the group-at-large to offer a comprehensive gene-to-structure service to customers, while creating entry points for Calibre Scientific into the ever-growing antibody space.
Read MoreStoneCalibre is pleased to announce the formation of Calibre Scientific, Inc., a Delaware holding company, which will be a consolidation vehicle in the healthcare life sciences industry under the leadership of Ben Travis as its Chief Executive Officer. As part of the Company’s formation, StoneCalibre contributed the six life sciences acquisitions it has made over the last four years that, today, collectively represent a diversified portfolio in the life science tools and diagnostics sector.
Read More